Boehringer Ingelheim: Grundsteinlegung für neue biopharmazeutische Produktionsanlage bei Boehringer Ingelheim: Zügiger Baufortschritt in Wien-Meidling

Boehringer Ingelheim RCV GmbH & Co KG
Mag. Inge Homolka
Tel: +43 (0)1-80105-2230
Email: ingeborg.homolka(at)

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)